Free Trial

Nuveen LLC Invests $20.22 Million in DaVita Inc. $DVA

DaVita logo with Medical background

Key Points

  • Nuveen LLC has acquired 132,171 shares of DaVita Inc. for approximately $20.2 million, representing around 0.17% ownership of the company.
  • Analysis from trading firms suggests a consensus rating of "Hold" on DaVita shares, with a consensus target price set at $164.00.
  • DaVita reported earnings of $2.95 per share, exceeding estimates, alongside a revenue increase of 6.1% year-over-year to $3.38 billion.
  • Looking to export and analyze DaVita data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Nuveen LLC bought a new position in DaVita Inc. (NYSE:DVA - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 132,171 shares of the company's stock, valued at approximately $20,218,000. Nuveen LLC owned about 0.17% of DaVita as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Fifth Third Bancorp grew its holdings in shares of DaVita by 5.0% in the first quarter. Fifth Third Bancorp now owns 4,274 shares of the company's stock worth $654,000 after purchasing an additional 204 shares during the last quarter. Concurrent Investment Advisors LLC bought a new position in shares of DaVita in the first quarter worth approximately $223,000. Wealth Enhancement Advisory Services LLC grew its holdings in shares of DaVita by 22.5% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 4,351 shares of the company's stock worth $666,000 after purchasing an additional 800 shares during the last quarter. Envestnet Asset Management Inc. grew its holdings in shares of DaVita by 7.9% in the first quarter. Envestnet Asset Management Inc. now owns 55,255 shares of the company's stock worth $8,452,000 after purchasing an additional 4,048 shares during the last quarter. Finally, OneDigital Investment Advisors LLC bought a new position in shares of DaVita in the first quarter worth approximately $200,000. Institutional investors own 90.12% of the company's stock.

DaVita Trading Up 2.0%

NYSE:DVA traded up $2.7250 during trading hours on Friday, hitting $140.3050. The company had a trading volume of 714,621 shares, compared to its average volume of 854,957. DaVita Inc. has a 52 week low of $126.07 and a 52 week high of $179.60. The company has a market capitalization of $10.03 billion, a PE ratio of 13.80, a price-to-earnings-growth ratio of 1.01 and a beta of 1.09. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.39 and a quick ratio of 1.34. The stock has a 50-day moving average price of $139.63 and a 200 day moving average price of $143.90.

DaVita (NYSE:DVA - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $2.95 EPS for the quarter, beating analysts' consensus estimates of $2.70 by $0.25. DaVita had a net margin of 6.35% and a return on equity of 369.39%. The firm had revenue of $3.38 billion for the quarter, compared to analysts' expectations of $3.36 billion. During the same quarter in the previous year, the business posted $2.00 EPS. The company's quarterly revenue was up 6.1% on a year-over-year basis. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. On average, equities research analysts predict that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Analysts Set New Price Targets

Several brokerages have recently issued reports on DVA. Wall Street Zen upgraded shares of DaVita from a "hold" rating to a "buy" rating in a report on Friday. Barclays cut their price target on shares of DaVita from $169.00 to $160.00 and set an "equal weight" rating on the stock in a report on Thursday, August 7th. Finally, Truist Financial set a $148.00 price target on shares of DaVita in a report on Friday, August 8th. Three analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $164.00.

Read Our Latest Analysis on DaVita

Insider Activity at DaVita

In other news, insider James O. Hearty sold 2,351 shares of the business's stock in a transaction on Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total transaction of $352,650.00. Following the sale, the insider owned 26,038 shares in the company, valued at approximately $3,905,700. The trade was a 8.28% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 1.50% of the company's stock.

About DaVita

(Free Report)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

See Also

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

Should You Invest $1,000 in DaVita Right Now?

Before you consider DaVita, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.

While DaVita currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines